invasive breast carcinoma
Showing 26 - 50 of 70
HER2-Positive Breast Carcinoma, Invasive Breast Carcinoma, Metastatic Malignant Tumor in the Brain Trial in Canada, Korea,
Completed
- HER2-Positive Breast Carcinoma
- +4 more
- Laboratory Biomarker Analysis
- +3 more
-
Birmingham, Alabama
- +301 more
Jun 28, 2022
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 Trial
Not yet recruiting
- Anatomic Stage I Breast Cancer AJCC v8
- +5 more
-
Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
Jul 14, 2022
Breast Adenocarcinoma, Invasive Breast Carcinoma, Metastatic Breast Carcinoma Trial in United States (drug, biological, other)
Active, not recruiting
- Breast Adenocarcinoma
- +9 more
- Entinostat
- +4 more
-
Duarte, California
- +4 more
Jul 16, 2022
Breast Ductal Carcinoma In Situ, Invasive Breast Carcinoma Trial in Duarte (Agent Affecting Integumentary System,
Recruiting
- Breast Ductal Carcinoma In Situ
- Invasive Breast Carcinoma
- Agent Affecting Integumentary System
- +3 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jun 30, 2022
Breast Carcinoma, Invasive Breast Carcinoma Trial in Houston (procedure, other, drug)
Active, not recruiting
- Breast Carcinoma
- Invasive Breast Carcinoma
- Contrast-Enhanced Mammography
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Jun 29, 2022
Invasive Breast Carcinoma, Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7 Trial in United States
Recruiting
- Invasive Breast Carcinoma
- +8 more
- Hypofractionated Radiation Therapy
- +4 more
-
Gilbert, Arizona
- +8 more
Jun 23, 2022
Invasive Breast Carcinoma, Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7 Trial in Detroit (Laboratory Biomarker
Active, not recruiting
- Invasive Breast Carcinoma
- +6 more
- Laboratory Biomarker Analysis
- Simvastatin
-
Detroit, MichiganWayne State University/Karmanos Cancer Institute
Jun 17, 2022
Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8
Recruiting
- Anatomic Stage III Breast Cancer AJCC v8
- +12 more
- Carboplatin
- +5 more
-
Houston, TexasM D Anderson Cancer Center
Jun 16, 2022
Neoadjuvant Chemotherapy on Peripheral Blood Immune Phenotype in
Recruiting
- Invasive Breast Carcinoma
- Biospecimen Collection
-
Rochester, MinnesotaMayo Clinic in Rochester
Jun 16, 2022
Estrogen Receptor Positive, HER2/Neu Negative, Invasive Breast Carcinoma Trial in Houston (Radiation Therapy, Therapeutic
Active, not recruiting
- Estrogen Receptor Positive
- +3 more
- Radiation Therapy
- Therapeutic Conventional Surgery
-
Houston, TexasM D Anderson Cancer Center
Jun 14, 2022
Breast Cancer Female, Anatomic Stage IIB Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 Trial in Kampala
Completed
- Breast Cancer Female
- +11 more
- Cyclophosphamide
- +3 more
-
Kampala, Uganda
- +1 more
Jun 7, 2022
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial
Recruiting
- Anatomic Stage I Breast Cancer AJCC v8
- +21 more
-
Scottsdale, Arizona
- +2 more
May 31, 2022
Breast Adenocarcinoma, HER2/Neu Negative, Invasive Breast Carcinoma Trial in United States (Eribulin Mesylate, Laboratory
Suspended
- Breast Adenocarcinoma
- +4 more
- Eribulin Mesylate
- +3 more
-
Scottsdale, Arizona
- +38 more
May 25, 2022
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial
Recruiting
- Anatomic Stage I Breast Cancer AJCC v8
- +22 more
- Microbiota-based Formulation RBX7455
-
Jacksonville, FloridaMayo Clinic in Florida
May 12, 2022
Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, Anatomic Stage IIB Breast Cancer AJCC v8
Recruiting
- Anatomic Stage II Breast Cancer AJCC v8
- +19 more
- Carboplatin
- +7 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
May 11, 2022
Invasive Breast Carcinoma, Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7 Trial in United States (drug, other,
Recruiting
- Invasive Breast Carcinoma
- +11 more
- Chemotherapy
- +4 more
-
Conroe, Texas
- +4 more
May 3, 2022
Collecting Blood Samples From and Without Cancer to Evaluate
Not yet recruiting
- Acute Lymphoblastic Leukemia
- +61 more
- Questionnaire Administration
- Biospecimen Collection
- (no location specified)
Apr 12, 2022
Invasive Breast Carcinoma, Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7 Trial in Houston (procedure, drug,
Recruiting
- Invasive Breast Carcinoma
- +11 more
- Axillary Lymph Node Dissection
- +5 more
-
Houston, Texas
- +1 more
Mar 10, 2022
Bilateral Breast Carcinoma, HER2/Neu Negative, Invasive Breast Carcinoma Trial in Oak Lawn, Houston (Best Practice, Ixabepilone)
Active, not recruiting
- Bilateral Breast Carcinoma
- +2 more
- Best Practice
- Ixabepilone
-
Oak Lawn, Illinois
- +2 more
Mar 10, 2022
Invasive Breast Carcinoma, Triple-Negative Breast Carcinoma Trial in Houston (biological, drug, other)
Active, not recruiting
- Invasive Breast Carcinoma
- Triple-Negative Breast Carcinoma
- Bevacizumab
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Feb 18, 2022
Breast Cancer, Invasive Breast Carcinoma Trial in Seattle (Aerobic Exercise Intervention, Resistance Exercise Intervention,
Recruiting
- Breast Cancer
- Invasive Breast Carcinoma
- Aerobic Exercise Intervention
- +4 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Feb 24, 2022
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial
Active, not recruiting
- Anatomic Stage I Breast Cancer AJCC v8
- +22 more
- Biopsy
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Feb 25, 2022
Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8 Trial
Recruiting
- Anatomic Stage IA Breast Cancer AJCC v8
- +21 more
- Trastuzumab Emtansine
- +4 more
-
Birmingham, Alabama
- +897 more
Feb 16, 2022
Anatomic Stage IV Breast Cancer AJCC v8, Invasive Breast Carcinoma, Metastatic Breast Adenocarcinoma Trial in Rochester
Recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- +4 more
- Oncolytic Measles Virus Encoding Helicobacter pylori Neutrophil-activating Protein
-
Rochester, MinnesotaMayo Clinic in Rochester
Feb 2, 2022
Benign Breast Tumor, Ductal Breast Carcinoma In Situ, Invasive Breast Carcinoma Trial in Boston, New York, Houston
Completed
- Benign Breast Neoplasm
- +11 more
- Docosahexaenoic Acid
- Placebo
-
Boston, Massachusetts
- +3 more
Dec 3, 2021